Where does Pfizer's $160bn acquisition of Allergan rank in the top ten?
November 2015 update: The latest mega-merger between healthcare giant Pfizer and Allergan has shaken up the industry, creating the largest drugmaker in the world. The merger has become the third largest...
Could spell risks for investors
UK economy hits a seven-year low
William Ball, senior equity analyst at Sanlam Private Wealth, discusses the advantage of underappreciated companies during times of market uncertainty.
Despite underperformance in June
Effective 20 July